155 related articles for article (PubMed ID: 9386841)
1. Single compartment models for evaluating beta 2-microglobulin clearance during hemodialysis.
Leypoldt JK; Cheung AK; Deeter RB
ASAIO J; 1997; 43(6):904-9. PubMed ID: 9386841
[TBL] [Abstract][Full Text] [Related]
2. Rebound kinetics of beta2-microglobulin after hemodialysis.
Leypoldt JK; Cheung AK; Deeter RB
Kidney Int; 1999 Oct; 56(4):1571-7. PubMed ID: 10504510
[TBL] [Abstract][Full Text] [Related]
3. Intradialytic kinetics of middle molecules during hemodialysis and hemodiafiltration.
Leypoldt JK; Storr M; Agar BU; Boschetti-de-Fierro A; Bernardo AA; Kirsch AH; Rosenkranz AR; Krieter DH; Krause B
Nephrol Dial Transplant; 2019 May; 34(5):870-877. PubMed ID: 30307514
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of beta2-microglobulin and phosphate during hemodialysis: effects of treatment frequency and duration.
Leypoldt JK
Semin Dial; 2005; 18(5):401-8. PubMed ID: 16191181
[TBL] [Abstract][Full Text] [Related]
5. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
6. Maintaining blood compartment volume in dialyzers reprocessed with peracetic acid maintains Kt/V but not beta2-microglobulin removal.
Ouseph R; Smith BP; Ward RA
Am J Kidney Dis; 1997 Oct; 30(4):501-6. PubMed ID: 9328364
[TBL] [Abstract][Full Text] [Related]
7. The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients.
Petersen J; Moore RM; Kaczmarek RG; Singh B; Yeh I; Hamburger S; Kankam M
Am J Kidney Dis; 1991 Feb; 17(2):174-8. PubMed ID: 1992659
[TBL] [Abstract][Full Text] [Related]
8. National Kidney Foundation report on dialyzer reuse. Task Force on Reuse of Dialyzers, Council on Dialysis, National Kidney Foundation.
Am J Kidney Dis; 1997 Dec; 30(6):859-71. PubMed ID: 9398135
[TBL] [Abstract][Full Text] [Related]
9. Beta 2-microglobulin kinetics in maintenance hemodialysis: a comparison of conventional and high-flux dialyzers and the effects of dialyzer reuse.
DiRaimondo CR; Pollak VE
Am J Kidney Dis; 1989 May; 13(5):390-5. PubMed ID: 2655439
[TBL] [Abstract][Full Text] [Related]
10. Effect of formaldehyde/bleach reprocessing on in vivo performances of high-efficiency cellulose and high-flux polysulfone dialyzers.
Murthy BV; Sundaram S; Jaber BL; Perrella C; Meyer KB; Pereira BJ
J Am Soc Nephrol; 1998 Mar; 9(3):464-72. PubMed ID: 9513910
[TBL] [Abstract][Full Text] [Related]
11. Effect of hemodialyzer reuse: dissociation between clearances of small and large solutes.
Leypoldt JK; Cheung AK; Deeter RB
Am J Kidney Dis; 1998 Aug; 32(2):295-301. PubMed ID: 9708616
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of urea and beta-microglobulin during and after short hemodialysis treatments.
Leypoldt JK; Cheung AK; Deeter RB; Goldfarb-Rumyantzev A; Greene T; Depner TA; Kusek J
Kidney Int; 2004 Oct; 66(4):1669-76. PubMed ID: 15458465
[TBL] [Abstract][Full Text] [Related]
13. Determination of extra renal clearance and generation rate of beta2-microglobulin in hemodialysis patients using a kinetic model.
Xu XQ; Gruner N; Al-Bashir A; Trutt-Ibing CH; Melzer H; Fassbinder W; Stiller JS; Manm H
ASAIO J; 2001; 47(6):623-7. PubMed ID: 11730200
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Circulating Levels of Uremic Toxins in Hemodialysis Patients Treated with Medium Cut-Off Membranes and High-Flux Membranes: Theranova in Sisli Hamidiye Etfal (THE SHE) Randomized Control Study.
Sevinc M; Hasbal NB; Yilmaz V; Basturk T; Ahbap E; Sakaci T; Ozcafer PN; Unsal A
Blood Purif; 2020; 49(6):733-742. PubMed ID: 32634815
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of four different high-flux hemodialyzers under conventional conditions in vivo.
Sombolos K; Tsitamidou Z; Kyriazis G; Karagianni A; Kantaropoulou M; Progia E
Am J Nephrol; 1997; 17(5):406-12. PubMed ID: 9382156
[TBL] [Abstract][Full Text] [Related]
16. Revisiting the Middle Molecule Hypothesis of Uremic Toxicity: A Systematic Review of Beta 2 Microglobulin Population Kinetics and Large Scale Modeling of Hemodialysis Trials In Silico.
Roumelioti ME; Nolin T; Unruh ML; Argyropoulos C
PLoS One; 2016; 11(4):e0153157. PubMed ID: 27055286
[TBL] [Abstract][Full Text] [Related]
17. Analysis of beta(2)-microglobulin kinetics in hemodialysis by a modified variable-volume one-compartment model.
Yamada T; Akiba T; Sasaki S
Blood Purif; 2001; 19(4):388-94. PubMed ID: 11574735
[TBL] [Abstract][Full Text] [Related]
18. What is good about PD + HD combined therapy.
Yamashita AC; Tomisawa N
Hemodial Int; 2011 Oct; 15 Suppl 1():S15-21. PubMed ID: 22093595
[TBL] [Abstract][Full Text] [Related]
19. Reprocessing high-flux polysulfone dialyzers does not negatively impact solute removal in short-daily online hemodiafiltration.
Melo NC; Moyses RM; Elias RM; Castro MC
Hemodial Int; 2014 Apr; 18(2):473-80. PubMed ID: 24393428
[TBL] [Abstract][Full Text] [Related]
20. Beta-2-microglobulin in hemodialysis patients. Effects of different dialyzers and different dialysis procedures.
Mayer G; Thum J; Woloszczuk W; Graf H
Am J Nephrol; 1988; 8(4):280-4. PubMed ID: 3055992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
